Bringing a new product from conception to market in the pharmaceutical industries is a laborious process – one that involves millions of dollars and extensive resource commitments to R&D and clinical trials over an average of eight years or more. At PSC Investments we help you mitigate these costs and bring your product to market faster by offering services to boost your success rate with in-or out-licensing technologies and patents. We help companies generate funds, mitigate risk factors, increase potential profits, resolve pipeline issues, and access new or expanded markets while reducing the overall time and cost of getting to market. We provide extensive due diligence, research, and analytics for both sides of licensing and partnership agreements to ensure a quick, fair negotiation process.
Creating new networks in expanded markets is both resource- and cost-intensive. We provide our clients with a competitive advantage by utilizing our standing relationships with venture capitalists, angel investors, and business development professionals worldwide. We can source, facilitate, and cultivate business-to-business relationships by using our vast network of life science clients, allies, and partners in order to find the ideal candidate.
Licensing & Partnership Services at PSC Investments include:
- Market Intelligence
- Corporate Intelligence
- Strategic Planning
- Negotiation Support
- Due Diligence Processes
- Identification of Potential Partnerships and Opportunities
- Regulatory Filing Support
- Management of Deals Post-Negotiation
- License Pricing
- Valuation Services